Hypothesis

Age‑associated mitochondrial oxidative stress in the zona reticularis triggers NLRP3 inflammasome activation, which suppresses steroidogenic enzymes (CYP17A1, HSD3B2) and promotes DHEA depletion, while concurrent inflammasome‑mediated glucocorticoid receptor resistance in hippocampal feedback nuclei blunts cortisol termination, producing elevated basal cortisol and a blunted cortisol awakening response.

Mechanistic Rationale

• Mitochondrial ROS accumulation: Aging adrenal cells exhibit increased electron‑leak respiration, raising superoxide that oxidizes cardiolipin and releases mitochondrial DNA into the cytosol, a canonical NLRP3 activator【2†https://pmc.ncbi.nlm.nih.gov/articles/PMC10426230/】.
• NLRP3 inflammasome signaling: Cytosolic mtDNA and ROS engage NLRP3, leading to caspase‑1 cleavage and IL‑1β/IL‑18 secretion. IL‑1β directly inhibits CYP17A1 transcription via NF‑κB–mediated repression, curtailing DHEA synthesis【2†https://pmc.ncbi.nlm.nih.gov/articles/PMC10426230/】.
• Glucocorticoid receptor (GR) resistance: IL‑1β phosphorylates GR at serine‑226, reducing its ligand‑binding affinity and nuclear translocation. Impaired GR feedback diminishes hippocampal inhibition of CRH/ACTH, sustaining adrenal cortisol output despite high circulating levels【1†https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2019.00054/full】.
• Sex‑dimorphic modulation: Estrogen enhances NLRP3 activation in females, whereas testosterone promotes antioxidant pathways (e.g., Nrf2) in males, offering a mechanistic basis for divergent CAR‑telomere relationships【2†https://pmc.ncbi.nlm.nih.gov/articles/PMC10426230/】.

Testable Predictions

1. Aged mice will show elevated mito‑ROS, NLRP3 inflammasome components (ASC, cleaved caspase‑1), and IL‑1β in zona reticularis compared with young adults.
2. Pharmacological inhibition of NLRP3 (MCC950) or mitochondrial antioxidant treatment (MitoQ) will restore DHEA levels, normalize CAR magnitude, and reduce basal corticosterone.
3. GR phosphorylation at serine‑226 will increase with age and correlate inversely with hippocampal GR nuclear localization; this will be rescued by inflammasome blockade.
4. Female mice will exhibit greater NLRP3 activation and DHEA loss than males; ovariectomy will attenuate the sex difference, while testosterone supplementation will exacerbate it in castrated males.

Experimental Design

• Subjects: Young (3 mo) and aged (24 mo) male and female C57BL/6J mice; subgroups receive MitoQ (10 mg/kg/day, oral) or MCC950 (10 mg/kg i.p., q48h) for 8 weeks.
• Readouts:
  • Adrenal zona reticularis thickness (histology, CYP17A1 immunostaining).
  • Mitochondrial ROS (MitoSOX flow cytometry).
  • NLRP3 inflammasome assembly (ASC speck assay, western blot for cleaved caspase‑1).
  • Steroid serum levels (LC‑MS/MS for corticosterone, DHEA).
  • CAR surrogate: serial tail‑bleed corticosterone at lights‑on, +30 min, +60 min.
  • Hippocampal GR phosphorylation (p‑Ser226) and nuclear/cytoplasmic fractionation.
  • Behavioral assays: corticosterone‑dependent memory (novel object recognition) and anxiety (elevated plus maze).
• Statistical plan: Two‑way ANOVA (age × treatment) with sex as a factor; post‑hoc Tukey; power analysis targeting n = 10/group for 80 % power to detect 25 % change.

Potential Outcomes and Implications

If NLRP3 inhibition or mito‑ROS scavenging rescues DHEA synthesis and normalizes CAR, the hypothesis would be supported, positioning the inflammasome as a nexus linking adrenal aging to HPA‑axis dysfunction. Failure to observe these changes would falsify the proposed mechanism, redirecting focus toward alternative drivers such as autonomic neuropathy or extracellular‑matrix remodeling. Demonstrating sex‑specific modulation would further elucidate why CAR predicts telomere length differently in men versus women, offering biomarkers (e.g., circulating IL‑1β, mitochondrial DNA) for personalized intervention strategies in age‑related stress disorders.